iifl-logo-icon 1

Cian Healthcare Ltd Board Meeting

23.84
(2.98%)
Jul 3, 2024|12:00:00 AM

Cian Healthcare CORPORATE ACTIONS

05/07/2023calendar-icon
04/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting14 Jun 20249 Jun 2024
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2024 inter alia to consider and approve To Discuss and reconsider the Investment Planning and Fund-raising Proposal etc.
Board Meeting5 Jun 20241 Jun 2024
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2024 inter alia to consider and approve To Discuss and Consider the Investment Planning and Fund-raising Proposal mode of funding To authorized Mr. Suraj Zanwar- Managing Director of company to prepare details plan of Investment proposal and working capital requirement of the company (As Per BSE Announcement Dated on 09.06.2024)
Board Meeting30 May 202420 May 2024
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve To consider and approve Audited financial results for Year ended on 31st march 2024 Revised financials for financial year ending on 31st march 2024 due to mission of attachment consolidated results (As Per BSE Announcement Dated on 31.05.2024)
Board Meeting17 Jan 202418 Jan 2024
Intimation of Appointment of Mr. Prateek Shriprakash Kulkarni as an Independent Director of company w.e.f. 17th January, 2024
Board Meeting30 Dec 202330 Dec 2023
Revised Outcome of Board meeting for migration of Companys present listing of equity shares from SME Platform of BSE Limited to Main Board of NSE Platform. Filing revised Outcome as in earlier outcome we by mistake mentioned as NSE Emerge instead of NSE Main Board. Migration of Companys present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of NSE Emerge Platform.
Board Meeting14 Nov 20236 Nov 2023
Half Yearly Results Outcome of Meeting of board of Director dated 14th November, 2023 Declaration of financial results for the half year ended on 30th September, 2023 (As Per BSE Announcement Dated on 14/11/2023)
Board Meeting12 Oct 202312 Oct 2023
Intimation of appointment of Additional Director (Executive category) w.e.f 11th October, 2023.

Cian Healthcare: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.